lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients.
about
lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
lncRNA MALAT1, HOTTIP and PVT1 ...... of pancreatic cancer patients.
@en
lncRNA MALAT1, HOTTIP and PVT1 ...... of pancreatic cancer patients.
@nl
type
label
lncRNA MALAT1, HOTTIP and PVT1 ...... of pancreatic cancer patients.
@en
lncRNA MALAT1, HOTTIP and PVT1 ...... of pancreatic cancer patients.
@nl
prefLabel
lncRNA MALAT1, HOTTIP and PVT1 ...... of pancreatic cancer patients.
@en
lncRNA MALAT1, HOTTIP and PVT1 ...... of pancreatic cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
lncRNA MALAT1, HOTTIP and PVT1 ...... of pancreatic cancer patients.
@en
P2093
Cui-Juan Wang
Sheng-Bin Shi
Zuo-Xing Niu
P2860
P304
95108-95115
P356
10.18632/ONCOTARGET.19345
P407
P577
2017-07-18T00:00:00Z